Overall Technical outlook

Price Summary

On 2025-07-16, Suven Pharmaceuticals Limited's stock opened at 1059.0, peaked at 1071.95, hit a low of 1054.4, and closed 0.45% higher at 1063.8, with 191992 shares changing hands.
The top price for the stock in the last 52 weeks is 1334.2, with the bottom price being 944.1.
The anticipated price is forecasted to be between 1290.0 and 1500.0, with an average price expectation of 1396.6666, based on input from 6 analysts.

Technicals

Support and Resistance: The price is currently at 1063.8, supported by 1048.2 and resisted by 1113.1. This indicates a range where 1048.2 may provide a base for the price, while 1113.1 serves as a cap on further upward movement for SUVENPHAR.
SUVENPHAR supportResistance f1cf75
Support/Resistance for SUVENPHAR


Aroon: The AROON is showing a neutral stance, with no definitive indication of an upward or downward trend for SUVENPHAR. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
SUVENPHAR aroon f1cf75
Aroon chart for Suven Pharmaceuticals Limited


Bol. Bands: The latest price move has seen the current price cross above the upper Bollinger Band, marking a bullish signal. This upward break indicates strong buying pressure, pushing prices beyond their normal range. Traders may see this as a sign of increasing momentum, with the potential for further upward price action.
SUVENPHAR bbands f1cf75
Bolinger Bands chart for Suven Pharmaceuticals Limited


Parabolic SAR: The PSAR for SUVENPHAR continues to be bullish, establishing a crucial support level that may help maintain the current upward trend. This level of support suggests that the market is poised to continue its positive trajectory, offering a foundation for further growth.
SUVENPHAR psar f1cf75
Parabolic Stop and Reverse chart for Suven Pharmaceuticals Limited


Stochastic: The stochastic indicator for Suven Pharmaceuticals Limited reflects a bullish sentiment, as the K-line is above both the D-line and the 80 threshold. This setup points to strong upward momentum, implying that the market may continue to rise. Traders could consider this as an indication of sustained bullish activity.
SUVENPHAR stoch f1cf75
Stochastic chart for Suven Pharmaceuticals Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
SUVENPHAR trippleSMA f1cf75
Tripple SMA chart for Suven Pharmaceuticals Limited


A comprehensive approach to analyzing a company requires considering both its technical and fundamental aspects. The company's fundamentals, such as its earnings, growth prospects, and financial health, provide a strong foundation for understanding technical indicators. Additionally, examining the industry it operates in helps contextualize the company's position within the broader market. By integrating these factors, one can gain more valuable insights into the company's stock performance and potential investment opportunities.